Rockville, MD, United States of America

Christian Furlan Freguia

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Christian Furlan Freguia: Innovator in Oncology Treatments

Introduction

Christian Furlan Freguia is an accomplished inventor based in Rockville, MD, known for his significant contributions to the field of oncology. With a total of six patents to his name, he has focused his efforts on developing treatments that mitigate the side effects of chemotherapy, showcasing his dedication to improving patient care.

Latest Patents

Freguia's latest patents include innovations in alkaline phosphate-based oncology treatments. His notable work involves methods and compositions aimed at preventing, treating, or reducing chemotherapy treatment-mediated side effects, particularly gastrointestinal issues. This is achieved through the administration of intestinal alkaline phosphatases (IAP). Additionally, he has developed alkaline phosphatase formulations, introducing modified-release powder formulations that deliver substantial amounts of the alkaline phosphatase-based agent directly to the intestines, providing various therapeutic uses.

Career Highlights

Throughout his career, Christian Furlan Freguia has made a significant impact in the biotech industry. He has held key positions in companies such as Theriva Biologics, Inc. and Synthetic Biologics, Inc., where he contributed to the advancement of biochemical solutions in healthcare. His work is characterized by a commitment to innovation and improving treatment outcomes for patients undergoing chemotherapy.

Collaborations

Freguia has collaborated with esteemed colleagues in the field, including Michael Kaleko and Vincent Wacher. These partnerships have fostered an environment of creativity and shared knowledge, ultimately enhancing the effectiveness of the inventions and solutions they work on.

Conclusion

In summary, Christian Furlan Freguia stands out as a pivotal figure in oncology innovation. With a proven track record of patenting innovative treatments that address critical challenges in chemotherapy, he continues to contribute value to the healthcare industry through his expertise and dedication to advancing medical science. His work not only showcases his inventive spirit but also reflects a commitment to enhancing patient outcomes in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…